Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables

被引:48
作者
Braeckman, L
De Bacquer, D
Delanghe, J
Claeys, L
De Backer, G
机构
[1] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium
[2] Univ Ghent, Dept Clin Chem, B-9000 Ghent, Belgium
关键词
haptoglobin; apo E; polymorphism; lipids; lipoproteins; interaction;
D O I
10.1016/S0021-9150(98)00330-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The haptoglobin allele frequencies and the phenotype distribution were determined in 741 male Caucasian workers, aged 35 to 59 years. The association of the haptoglobin polymorphism with various clinical and biochemical parameters was investigated. Furthermore a possible interaction with the apo E polymorphism on lipid and lipoprotein traits was analysed. The frequency of Hpl and Hp2 was found to be 0.401 and 0.599, respectively. The observed distribution of Hp types (Hp 1-1, 15.5%; Hp 2-1, 49.3%; Hp 2-2, 35.2%) was in Hardy-Weinberg equilibrium. Age, body mass index, smoking, alcohol intake and blood pressure were comparable between the three Hp groups. Subjects with Hp 2-2 had significantly higher serum total and free cholesterol concentration compared to those in other haptoglobin types (P = 0.006 and P = 0.003). Similarly, apo B levels were significantly higher among Hp 2-2 individuals (P = 0.02). No significant differences were demonstrated between the Hp phenotypes in HDL cholesterol, apo A-I, apo E, Lp(a), cholesteryl esters, fibrinogen and C-reactive protein concentrations, although for the latter an increase was noticed in Hp 2-2. The effects of Hp type and apo E type on Lp(a) and on fret: cholesterol levels were found to be significantly multiplicative, with the highest free cholesterol values observed in subjects having Hp 2-2 and the apo epsilon 4 allele. Significantly lower Lp(a) levels were observed in individuals carrying Hp 1-1 and an epsilon 2 allele than in subjects without the epsilon 2 allele. In conclusion, haptoglobin polymorphism may play an important role in the regulation of lipoprotein metabolism and could contribute to the risk of coronary heart disease. Larger samples are needed to clarify the clinical relevance of the gene-gene (Hp-apo E) interaction on lipids and lipoproteins. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:383 / 388
页数:6
相关论文
共 30 条
[1]   EFFECT OF HAPTOGLOBIN SUBTYPES ON SERUM-LIPID LEVELS [J].
BORRESEN, AL ;
LEREN, T ;
BERG, K ;
SOLAAS, MH .
HUMAN HEREDITY, 1987, 37 (03) :150-156
[2]   Apolipoprotein E polymorphism in middle-aged Belgian men: Phenotype distribution and relation to serum lipids and lipoproteins [J].
Braeckman, L ;
DeBacquer, D ;
Rosseneu, M ;
DeBacker, G .
ATHEROSCLEROSIS, 1996, 120 (1-2) :67-73
[3]   A SEARCH FOR ASSOCIATION BETWEEN GENE MARKERS AND SERUM-CHOLESTEROL, TRIGLYCERIDE, URATE AND BLOOD-PRESSURE [J].
BUCKTON, K ;
LAI, LYC ;
GIBSON, JB .
ANNALS OF HUMAN BIOLOGY, 1981, 8 (01) :39-48
[4]  
BURY J, 1986, CLIN CHEM, V32, P265
[5]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[6]   EFFECT OF THE HAPTOGLOBIN PHENOTYPE ON THE SIZE OF A MYOCARDIAL INFARCT [J].
CHAPELLE, JP ;
ALBERT, A ;
SMEETS, JP ;
HEUSGHEM, C ;
KULBERTUS, HE .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (08) :457-463
[7]   Regional serum cholesterol differences in Belgium: do genetically determined cardiovascular risk factors contribute? [J].
Cobbaert, C ;
Mulder, P .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1998, 27 (04) :605-613
[8]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[9]   RELATION OF FIBRINOGEN TO LIFE-STYLES AND TO CARDIOVASCULAR RISK-FACTORS IN A WORKING POPULATION [J].
DEBOEVER, E ;
DEBACQUER, D ;
BRAECKMAN, L ;
BAELE, G ;
ROSSENEU, M ;
DEBACKER, G .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1995, 24 (05) :915-921
[10]   Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery [J].
Delanghe, J ;
Cambier, B ;
Langlois, M ;
DeBuyzere, M ;
Neels, H ;
DeBacquer, D ;
VanCauwelaert, P .
ATHEROSCLEROSIS, 1997, 132 (02) :215-219